X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3213) 3213
Publication (210) 210
Newsletter (160) 160
Book Review (37) 37
Newspaper Article (26) 26
Magazine Article (15) 15
Book Chapter (12) 12
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2423) 2423
ganciclovir (1655) 1655
male (1278) 1278
ganciclovir - therapeutic use (1172) 1172
ganciclovir - administration & dosage (1164) 1164
female (1138) 1138
antiviral agents - therapeutic use (984) 984
antiviral agents - administration & dosage (909) 909
animals (882) 882
index medicus (873) 873
adult (853) 853
middle aged (735) 735
cytomegalovirus infections - drug therapy (686) 686
transplantation (649) 649
cytomegalovirus (613) 613
thymidine kinase - genetics (581) 581
cytomegalovirus infections - prevention & control (540) 540
mice (511) 511
immunology (449) 449
infection (442) 442
oncology (432) 432
cytomegalovirus infections (429) 429
disease (415) 415
treatment outcome (407) 407
health aspects (400) 400
ganciclovir - analogs & derivatives (394) 394
ganciclovir - pharmacology (389) 389
therapy (388) 388
administration, oral (359) 359
pharmacology & pharmacy (349) 349
gene therapy (344) 344
research (329) 329
ophthalmology (319) 319
drug therapy (318) 318
surgery (317) 317
genetic therapy - methods (308) 308
prevention (307) 307
aged (306) 306
medicine, research & experimental (301) 301
valganciclovir (295) 295
cytomegalovirus retinitis - drug therapy (294) 294
infectious diseases (285) 285
care and treatment (282) 282
risk factors (274) 274
adolescent (262) 262
simplexvirus - enzymology (262) 262
prophylaxis (261) 261
recipients (260) 260
aids (258) 258
virus diseases (258) 258
genetics & heredity (254) 254
cancer (251) 251
retrospective studies (248) 248
biotechnology & applied microbiology (247) 247
ganciclovir - adverse effects (241) 241
cytomegalovirus infections - diagnosis (236) 236
aids-related opportunistic infections - drug therapy (232) 232
antiviral agents - pharmacology (232) 232
time factors (224) 224
hematology (223) 223
dosage and administration (220) 220
cytomegalovirus - isolation & purification (218) 218
antiviral agents - adverse effects (213) 213
simplexvirus - genetics (211) 211
drug therapy, combination (210) 210
expression (210) 210
genetic therapy (210) 210
rats (209) 209
cytomegalovirus infections - complications (204) 204
cytomegalovirus infections - etiology (204) 204
genetic vectors (203) 203
polymerase chain reaction (196) 196
cells (195) 195
in-vivo (195) 195
ganciclovir - pharmacokinetics (194) 194
tumor cells, cultured (194) 194
viruses (194) 194
cytomegalovirus infections - virology (190) 190
child (186) 186
foscarnet (182) 182
cytomegalovirus - drug effects (181) 181
dose-response relationship, drug (178) 178
antiviral agents (177) 177
thymidine kinase (176) 176
infections (172) 172
adenoviridae - genetics (171) 171
cytomegalovirus retinitis (171) 171
drug administration schedule (170) 170
oral ganciclovir (168) 168
genetic aspects (167) 167
thymidine kinase - metabolism (166) 166
acyclovir (165) 165
follow-up studies (158) 158
prospective studies (157) 157
antiviral agents - pharmacokinetics (155) 155
acyclovir - therapeutic use (151) 151
cytomegalovirus - genetics (149) 149
pharmacokinetics (148) 148
gene transfer techniques (146) 146
mice, nude (146) 146
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3244) 3244
Japanese (42) 42
German (33) 33
French (32) 32
Spanish (25) 25
Chinese (22) 22
Polish (6) 6
Russian (6) 6
Hungarian (3) 3
Korean (3) 3
Danish (2) 2
Italian (2) 2
Portuguese (2) 2
Arabic (1) 1
Dutch (1) 1
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 933 - 943
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1256 - 1263
Summary Background Cytomegalovirus end-organ disease can be prevented by giving ganciclovir when viraemia is detected in allograft recipients. Values of viral... 
Internal Medicine | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | LIVER-TRANSPLANTATION | VIRUS | LOAD | DISEASE | PREVENTION | PREEMPTIVE THERAPY | RENAL-TRANSPLANTATION | INFECTION | VALGANCICLOVIR | Liver Transplantation | Adjuvants, Immunologic - administration & dosage | Viral Envelope Proteins - pharmacology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Organ Transplantation | Cytomegalovirus Vaccines - administration & dosage | Cytomegalovirus Infections - prevention & control | Time Factors | Polymerase Chain Reaction | Polysorbates - administration & dosage | Adult | Female | Immunosuppressive Agents - administration & dosage | Cytomegalovirus - genetics | Cytomegalovirus - isolation & purification | Viremia - diagnosis | Enzyme-Linked Immunosorbent Assay | Squalene - administration & dosage | Treatment Outcome | Kidney Transplantation | Viral Envelope Proteins - administration & dosage | Cytomegalovirus Infections - diagnosis | Antibodies, Viral - isolation & purification | Cytomegalovirus - immunology | Cytomegalovirus Vaccines - pharmacology | Viremia - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Organ transplant recipients | Usage | Viral vaccines | Cytomegaloviruses | Health aspects | Design | Clinical trials | Genomes | Disease | Blood products
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 11/2012, Volume 12, Issue 11, pp. 3021 - 3030
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 13, pp. 1227 - 1236
Journal Article
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 06/2010, Volume 51, Issue 6, pp. 3162 - 3170
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 12/2005, Volume 57, Issue 12, pp. 1555 - 1563
The purpose of this study was to determine the retention and ocular distribution of subconjunctivally administered nanoparticles and microparticles.... 
RETINAL DELIVERY | RAT | PARTICLES | CONTROLLED-RELEASE | GANCICLOVIR | ELIMINATION | PHARMACOLOGY & PHARMACY | NEOVASCULARIZATION | ACRYLIC MICROSPHERES INVIVO | VITREORETINAL DRUG-DELIVERY | BIODEGRADABLE SCLERAL IMPLANT | Particle Size | Drug Administration Routes | Animals | Sensitivity and Specificity | Rats | Male | Conjunctiva | Rats, Sprague-Dawley | Nanotechnology
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2015, Volume 209, pp. 260 - 271
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 4, pp. 284 - 292
Journal Article